investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Taccalonolides: Mechanisms of Action and Cellular Resistance
Susan L Mooberry
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Joan Massague
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
Breast
Mien-Chie Hung
Nuclear EGFR in Cancer Cell Signaling and Radioresistance
Breast
Radiation Oncology
Leo Masamba
Breast Cancer Receptor Study : Targeting HIV Associated Lymphoma in Malawi
Breast
Bing Xia
Targeting Autophagy in Hereditary Breast Cancer
Breast
Michael J Holliday
Mapping and Controlling the Segmental Dynamic Networks of Cyclophilin A as they Relate to Enzymatic Function
Breast
Pier Paolo Pandolfi
PTEN in ontogenesis and tumor suppression
Breast
Maxwell Lee
Genetics and Epigenetics of Cancer
Breast
Svetlana Bortnik
The effects of autophagy knockdown in breast cancer cells using in vivo xenograft models
Breast
Marcel Bally
Identifying Cytoprotective Responses Triggered Following Initial Exposure to Targeted Therapy: Defining Improved Treatment Strategies for Patients with HER-2 Positive Breast Cancer
Breast